secwatch / observer

8-K filed June 1, 2026, 8:05 AM ET ticker CABR CIK 0002020737

other material confidence medium sentiment positive materiality 0.60

Caring Brands expands licensing deal for Photocil and Hair Enzyme Booster to 5-year term, new territories

Caring Brands, Inc.

Revised five-year licensing agreement effective May 21, 2026, expands territories to India (existing), LATAM, Russia, Australia, and New Zealand.
SCPL's existing sublicense partners include Eris, Dr. Reddy's, Cipla, Dabur, Glenmark for Hair Enzyme Booster in multiple Asian and Middle Eastern markets.
Photocil (commercialized as Photofirst by Eris) is a patented topical for vitiligo, psoriasis, and atopic dermatitis.
Hair Enzyme Booster is a first-of-its-kind topical that increases SULT1A1 enzyme to convert Minoxidil into active form for hair growth.
CEO Glynn Wilson stated the expanded agreement reflects confidence in SCPL and aims to improve revenue stream.

item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-26-026533
form_type: 8-K
ticker: CABR
cik: 0002020737
company_name: Caring Brands, Inc.
filed_at: 2026-06-01T12:05:42+00:00
discovered_at: 2026-06-01T12:10:00.344562+00:00
generated_at: 2026-06-01T12:11:51.761434+00:00
sec_items: ["7.01", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: medium
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-26-026533
json_url: https://secwatch.observer/filing/0001493152-26-026533.json
markdown_url: https://secwatch.observer/filing/0001493152-26-026533.md
text_url: https://secwatch.observer/filing/0001493152-26-026533.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/2020737/000149315226026533/0001493152-26-026533-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/2020737/000149315226026533/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

DBX

Dropbox secures $400M revolving credit facility, authorizes $900M share repurchase program

DROPBOX, INC. June 1, 2026, 9:06 AM ET other_material Items 1.01, 2.03, 7.01, 8.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

BMNR

Bitmine holds 5.42M ETH (4.49% of supply); total crypto + cash = $11.6B

BITMINE IMMERSION TECHNOLOGIES, INC. June 1, 2026, 8:45 AM ET other_material Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

AIRJ

AirJoule Technologies raises $15M in registered direct offering at $4.10/share

AirJoule Technologies Corp. June 1, 2026, 8:34 AM ET other_material Items 1.01, 5.07, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

TMQ

Trilogy Metals extends closing date for $35.6M DOW investment to July 31, 2026

Trilogy Metals Inc. June 1, 2026, 7:09 AM ET other_material Items 1.01, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

FVR

FrontView REIT reports Q2 net investment target on track; Amazon lease and Dollar Tree portfolio upgrade

FrontView REIT, Inc. June 1, 2026, 7:05 AM ET other_material Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

QBTS

D-Wave unveils gate-model roadmap targeting 100 logical qubits by 2032

D-Wave Quantum Inc. June 1, 2026, 7:01 AM ET other_material Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

INVH

InvH April-May SS occupancy 97.2%, rent growth 2.5%; valuation discount to NAV

Invitation Homes Inc. June 1, 2026, 6:45 AM ET other_material Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

MNPR

Monopar presents Phase 2 data for ALXN1840 in Wilson disease at EASL 2026

Monopar Therapeutics May 29, 2026, 4:56 PM ET other_material Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001493152-26-026533

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.